Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-07-16GLUE144MARKUS WARMUTH plan to sell securities of MONTE ROSA THERAPEUTICS, INC. under Form 144MEDIUM
MARKUS WARMUTH filed Form 144 to notify SEC of plan to sell 9500 units of MONTE ROSA THERAPEUTICS, INC. securities around 2026-07-16, with aggregate market value of $220,218.55. The total outstanding units is 84479418.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions in p...
Small CapBiotechnology
2026-07-15ANNX144WIGGANS THOMAS G plan to sell securities of Annexon, Inc. under Form 144MEDIUM
WIGGANS THOMAS G filed Form 144 to notify SEC of plan to sell 2000 units of Annexon, Inc. securities around 2026-07-15, with aggregate market value of $12,630.01. The total outstanding units is 163842538.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3 months i...
Small CapBiotechnology
2026-07-15ARQT144Howard Welgus plan to sell securities of Arcutis Biotherapeutics, Inc. under Form 144MEDIUM
Howard Welgus filed Form 144 to notify SEC of plan to sell 4730 units of Arcutis Biotherapeutics, Inc. securities around 2026-07-15, with aggregate market value of $127,284.30. The total outstanding units is 125083374.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in p...
Mid CapBiotechnology